Scleroderma and drugs of ingredients of acyclovir (a real world drug study)

---

---

Number of reports submitted per year:

Gender of people who have Scleroderma when taking drugs with ingredients of acyclovir *:

• female: 37.5 %
• male: 62.5 %

Age of people who have Scleroderma when taking drugs with ingredients of acyclovir *:

• 0-1: 0.0 %
• 2-9: 0.0 %
• 10-19: 0.0 %
• 20-29: 0.0 %
• 30-39: 7.14 %
• 40-49: 14.29 %
• 50-59: 35.71 %
• 60+: 42.86 %

Conditions people have *:

You may use this to check any potential undetected conditions.

1. Nuclear Magnetic Resonance Imaging Brain: 5 people, 26.32%
2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 10.53%
3. Nuclear Magnetic Resonance Imaging Abdominal: 2 people, 10.53%
4. Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 2 people, 10.53%
5. Osteoporosis (bones weak and more likely to break): 1 person, 5.26%
6. Neoplasm Malignant (cancer tumour): 1 person, 5.26%
7. Ill-Defined Disorder: 1 person, 5.26%
8. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 5.26%

Other drugs people take *:

You may use this to check any potential interacting drugs.

1. Prednisone: 9 people, 47.37%
2. Ergocalciferol: 7 people, 36.84%
3. Fluconazole: 6 people, 31.58%
4. Hectorol: 5 people, 26.32%
5. Inderal: 5 people, 26.32%
6. Venofer: 5 people, 26.32%
7. Fosrenol: 5 people, 26.32%
8. Midodrine Hydrochloride: 5 people, 26.32%
9. Multihance: 5 people, 26.32%
10. Omniscan: 5 people, 26.32%

Other side effects people have besides Scleroderma *:

You may use this to check any potential undetected side effects.

1. Rashes (redness): 7 people, 36.84%
2. Pain: 6 people, 31.58%
3. Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 6 people, 31.58%
4. Joint Pain: 6 people, 31.58%
5. Pleural Fibrosis (formation of fibrous tissue in lung): 6 people, 31.58%
6. Gait Disturbance: 6 people, 31.58%
7. Mobility Decreased (ability to move is reduced): 5 people, 26.32%
8. Subcutaneous Nodule: 5 people, 26.32%
9. Skin Tightness: 5 people, 26.32%
10. Skin Plaque (red, scaly patches to appear on the skin): 5 people, 26.32%

---